Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The trial investigates the efficacy of adoptive immunotherapy with haploidentical natural killer cells compared to standard chemotherapy (after first complete remission) in patients with a high-risk acute myeloid leukemia being older than 65 years of age and not eligible for allogeneic transplantation
Epistemonikos ID: 661953842abf7c7654e5344ea14ba1769e84d8bc
First added on: Jan 21, 2022